Dec 11, 2020 / 04:00PM GMT
Operator
Good afternoon, and welcome to the Medicenna KOL webinar on MDNA55 for the treatment of recurrent glioblastoma multiforme. (Operator Instructions) As a reminder, this webinar is being recorded, and a replay will be made available on the Medicenna website following the event. .
I would now like to turn the call over to your host, Dr. Fahar Merchant, President and Chief Executive Officer of Medicenna. Please go ahead, Doctor.
Fahar Merchant - Medicenna Therapeutics Corp. - Founder, Chairman, CEO & President
Thank you, operator. Good morning, everyone, and welcome to today's key opinion leader event. Before I begin, I would like to remind everyone that during the presentations and the Q&A session to follow, forward-looking statements may be made as disclosed on this slide.
Next slide, please. I would also like to thank our key opinion leaders, Dr. David Reardon, Dr. John Sampson; Dr. Ruthie Davi, and Dr. Amy McKee, for graciously taking the time to join us on the webcast today.
Next slide, please. So today's event will focus on
Medicenna Therapeutics Corp. - Special Call Transcript
Dec 11, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers